|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B Kinase-2 Inhibitor of Interleukin-1–Induced Collagen Degradation by Corneal Fibroblasts in Three-Dimensional CultureFrom the Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Ube City, Yamaguchi, Japan.
PURPOSE. Corneal ulcer results from excessive collagen degradation in the corneal stroma. Interleukin (IL)-1 promotes this process by activating signaling molecules that include nuclear factor (NF)-
B and stimulating the synthesis of matrix metalloproteinases (MMPs) in corneal fibroblasts. NF-
B activation is mediated by phosphorylation of the inhibitor I
B by I
B kinase (IKK)-2 and consequent I
B degradation. The authors investigated the effects of the IKK-2 inhibitor [5-(p-fluorophenyl)-2-ureido]thiophene-3-carboxamide (TPCA-1) on collagen degradation by corneal fibroblasts.
METHODS. Rabbit corneal fibroblasts were cultured in three-dimensional collagen gels. Collagen degradation was evaluated by spectrophotometric quantitation of hydroxyproline in culture supernatants subjected to acid-heat hydrolysis. Expression of MMPs was evaluated by immunoblot analysis, gelatin zymography, and real-time reverse transcription polymerase chain reaction analysis. The phosphorylation and degradation of I
B
and the subcellular localization of NF-
B were examined by immunoblot and immunofluorescence analyses, respectively.
RESULTS. IL-1β–induced collagen degradation by corneal fibroblasts was inhibited by TPCA-1 in a concentration- and time-dependent manner. TPCA-1 inhibited the IL-1β–induced expression of MMP-1, -3, and -9 in these cells at both the mRNA and protein levels and the IL-1β–induced activation of pro-MMP-2. In contrast to dexamethasone, TPCA-1 inhibited the phosphorylation and degradation of I
B
and the nuclear translocation of NF-
B induced by IL-1β.
CONCLUSIONS. An IKK-2 inhibitor blocked IL-1β–induced collagen degradation by corneal fibroblasts by inhibiting the activation of the NF-
B signaling pathway and the upregulation of MMPs. IKK-2 inhibitors are thus potential alternatives to dexamethasone for the treatment of corneal ulcer.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |